Clinical use of radiation sensitizing agents

Cancer Treat Rev. 1974 Mar;1(1):15-26. doi: 10.1016/s0305-7372(74)80008-3.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / therapeutic use
  • Bleomycin / therapeutic use
  • Bromodeoxycytidine / therapeutic use
  • Bromodeoxyuridine / administration & dosage
  • Bromodeoxyuridine / therapeutic use
  • Bromouracil / therapeutic use
  • Carcinoma, Squamous Cell / radiotherapy
  • Dactinomycin / therapeutic use
  • Dose-Response Relationship, Radiation
  • Floxuridine / therapeutic use
  • Fluorouracil / therapeutic use
  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Hydroxyurea / therapeutic use
  • Idoxuridine / therapeutic use
  • Neoplasms / drug therapy
  • Neoplasms / radiotherapy*
  • Neoplasms, Experimental / radiotherapy
  • Radiation-Sensitizing Agents / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Radiation-Sensitizing Agents
  • Floxuridine
  • Bromodeoxycytidine
  • Bleomycin
  • Dactinomycin
  • Bromouracil
  • Bromodeoxyuridine
  • Idoxuridine
  • Fluorouracil
  • Hydroxyurea